Spinal implants are used to treat spinal problems like imbalance and instability. Around 2,500 people are injured or given a spinal cord injury diagnosis each year in the UK, according to the Spinal Injury Association UK. About 50,000 people are thought to be living with spinal cord injury. Devices used during spine surgery fall into two categories: fusion and non-fusion devices. In order to replace pro-inflammatory tissues, correct spinal alignment, and decompress neuronal elements without destroying their functional movements, non-fusion devices are used in the treatment.
The market worth of the spinal non-fusion devices market in 2021 was USD 3.88 billion, and it will be worth USD 6.08 billion by 2030, growing at a 5.1% CAGR During the forecast period.
Due to an increase in spinal illnesses, including degenerative disc disease, the market for spinal non-fusion devices will rise significantly during the forecast period. Although it also affects other segments, degenerative disc disease starts with abnormalities in the intervertebral discs.
With the growing cases of spinal illnesses, including degenerative disc disease, the market for spinal non-fusion devices is growing significantly. The first symptoms of degenerative disc disease are abnormalities in the intervertebral discs, which also impact the other segments. Degenerative disc disease (DDD), affecting about 40% of persons over 40, is becoming more common as people age. Non-spinal fusion procedures will rise due to the rise in degenerative disc disease (DDD), fueling the market’s expansion. Other variables include the acceptance of minimally invasive procedures like disc arthroscopy and their advantages over spinal fusion.
Due to a restriction on orthopedic services by hospitals and clinics to stop the spread of the COVID-19 virus and intense pressure on hospitals to treat COVID-19 patients, the global COVID-19 pandemic and lockdown situation in some countries has revealed some challenges in the spinal non-fusion devices market.
The need for spinal fusion devices is rising as minimally invasive surgery (MIS) gains popularity. For a variety of reasons, including less discomfort, a speedier recovery time, & a reduced chance of tissue injury, surgeons prefer MIS to open surgery. Numerous bone conditions are addressed using minimally invasive techniques.
On the basis of type, the market is segmented into total disc replacement devices, artificial disc replacement devices, partial disc replacement devices, Dynamic stabilization devices, and annulus repair devices.
In 2020, Dynamic Stabilization Devices had the greatest market share of spinal non-fusion devices. Devices that are available include facet replacement products, Pedicle screw-based systems, and interspinous process spacers. The segment’s dominance is due to stiff spinal implants for fusion technology. Furthermore, the segment’s expansion is considerably aided by the rising incidence of spinal degenerative disc illnesses.
On the basis of end-user, the market is segmented into specialty clinics and hospitals.
In 2020, the hospital sector held the largest proportion. This is because spine surgery payment policies are favorable and because spine navigation software is widely used. According to the journal Neurosurgery, spinal surgery conducted at ambulatory surgery centers can save USD 140 million annually.
In 2020, North America owned the largest percentage. Advanced fusion surgery is encouraged by favorable payment policies, elderly patients hoping for greater levels of function, and technical improvements, which have contributed to the growth of the spine surgery industry in the United States. The annual rate of spinal cord injury in the United States is approximately 54 per one million people, or about 17,810 new SCI-related cases each year, according to the (NSCIS) National Spinal Cord Injury Statistical Centre’s 2019 SCI Datasheet.
- Stryker Corporation
- NuVasive, Inc.
- Zimmer Biomet Holdings, Inc.
- Globus Medical, Inc.
- Paradigm Spine
The market worth of the spinal non-fusion devices market in 2021 was USD 3.88 billion, and it will be worth USD 6.08 billion by 2030, growing at a 5.1% CAGR During the forecast period. The two main drivers propelling the growth of the spinal non-fusion devices market are the rise in spinal injury cases and the aging population. However, high surgical costs may restrain the growth of the Spinal Non-Fusion Devices Market.